GlassScriptPhysician profile
Eric Q Pang
NPI 1780927533
$3,189.42
in general payments reported to CMS, 2019-2025
12 companies · $54.49 in 2025
The $54.49 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $407 · 2020: $26.23 · 2021: $2,526 · 2022: $51.47 · 2023: $103 · 2024: $21.87 · 2025: $54.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $178.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Summit Surgical Corp. | $2,423.04 | 2021 | |
| Medartis INC. | $146.20 | 2019 | |
| Stryker Corporation | $145.13 | 2020-2023 | Gamma |
| Checkpoint Surgical, INC | $121.30 | 2019 | |
| Acumed LLC | $119.75 | 2019-2025 | Acumed |
| Axogen | $49.67 | 2019-2023 | Avance Nerve Graft |
| Skeletal Dynamics INC | $46.68 | 2021 | |
| Endo USA, INC. | $43.09 | 2024-2025 | Xiaflex |
| Endo Pharmaceuticals INC. | $36.39 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $20.79 | 2019 | |
| Smith+Nephew, INC. | $19.16 | 2021 | |
| Bioventus LLC | $18.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Pang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.